A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Spontaneous Urticaria
Related studies linked through entity extraction aliases.
Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE3
OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy
- Status
- COMPLETED
- Phase
- PHASE3